Positive anti-citrullinated protein antibody status and small joint arthritis are consistent predictors of chronic disease in patients with very early arthritis: Results from the NOR-VEAC cohort

Arthritis Research and Therapy

Volumn 11, Issue 5, 2009, Pages

  Mjaavatten, Maria D ^a   Uhlig, Till ^a   Haugen, Anne J ^b   Nygaard, Halvor ^c   Sidenvall, Göran ^d   Helgetveit, Knut ^e   Kvien, Tore K ^a  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b Ostfold Hospital Trust   (Norway)

^c Hospital for Rheumatic Diseases   (Norway)

^d Innlandet Hospital   (Norway)

^e Martina Hansen Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOGLOBULIN M; ANTIRHEUMATIC AGENT; AUTOANTIBODY; CITRULLINE; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC ARTHRITIS; COHORT ANALYSIS; FEMALE; HUMAN; JOINT SWELLING; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METACARPOPHALANGEAL JOINT; METATARSOPHALANGEAL JOINT; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRESCRIPTION; PROXIMAL INTERPHALANGEAL JOINT; RHEUMATOID ARTHRITIS; SYNOVITIS; BLOOD; CHRONIC DISEASE; CLINICAL TRIAL; DISEASE COURSE; MIDDLE AGED; MULTICENTER STUDY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CHRONIC DISEASE; CITRULLINE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 75649101309     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2820     Document Type: Article

References (37)

1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
2. Harrison BJ, Symmons DP, Barrett EM, Silman AJ. The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association. J Rheumatol 1998, 25:2324-2330.
3. Kaarela K, Kauppi MJ, Lehtinen KE. The value of the ACR 1987 criteria in very early rheumatoid arthritis. Scand J Rheumatol 1995, 24:279-281. 10.3109/03009749509095163, 8533041.
4. Lunt M, Symmons DP, Silman AJ. An evaluation of the decision tree format of the American College of Rheumatology 1987 classification criteria for rheumatoid arthritis: performance over five years in a primary care-based prospective study. Arthritis Rheum 2005, 52:2277-2283. 10.1002/art.21203, 16052579.
5. Saraux A, Berthelot JM, Chales G, Le Henaff C, Thorel JB, Hoang S, Valls I, Devauchelle V, Martin A, Baron D, Pennec Y, Botton E, Mary JY, Le Goff P, Youinou P. Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum 2001, 44:2485-2491. 10.1002/1529-0131(200111)44:11<2485::AID-ART428>3.0.CO;2-S, 11710704.
6. Banal F, Dougados M, Combescure C, Gossec L. Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration: a systematic literature review and meta-analysis. Ann Rheum Dis 2009, 68:1184-1191. 10.1136/ard.2008.093187, 18728049.
7. Inanc M. Very early 'Rheumatoid' arthritis cohorts: limited by selection. Rheumatology (Oxford) 2007, 46:185-187. 10.1093/rheumatology/kel342, 17043049.
8. Scott DL. The diagnosis and prognosis of early arthritis: rationale for new prognostic criteria. Arthritis Rheum 2002, 46:286-290. 10.1002/art.10134, 11840430.
9. Symmons DP. Classification criteria for rheumatoid arthritis--time to abandon rheumatoid factor?. Rheumatology (Oxford) 2007, 46:725-726. 10.1093/rheumatology/kel418, 17215261.
10. Harrison B, Symmons D. Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years. Rheumatology (Oxford) 2000, 39:939-949. 10.1093/rheumatology/39.9.939, 10986297.
11. Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002, 46:357-365. 10.1002/art.10117, 11840437.
12. El Miedany Y, Youssef S, Mehanna AN, El Gaafary M. Development of a scoring system for assessment of outcome of early undifferentiated inflammatory synovitis. Joint Bone Spine 2008, 75:155-162. 10.1016/j.jbspin.2007.04.021, 17980637.
13. Aletaha D, Huizinga TW. The use of data from early arthritis clinics for clinical research. Best Pract Res Clin Rheumatol 2009, 23:117-123. 10.1016/j.berh.2008.11.008, 19233051.
14. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 2003, 1:20. 10.1186/1477-7525-1-20, 165587, 12831398.
15. Loge JH, Kaasa S, Hjermstad MJ, Kvien TK. Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol 1998, 51:1069-1076. 10.1016/S0895-4356(98)00098-5, 9817124.
16. Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995, 33:AS264-AS279. 10.1097/00005650-199501001-00005, 7723455.
17. Stucki G, Liang MH, Stucki S, Bruhlmann P, Michel BA. A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995, 38:795-798. 10.1002/art.1780380612, 7779122.
18. Syversen SW, Gaarder PI, Goll GL, Ødegård S, Haavardsholm EA, Mowinckel P, Heijde DM, Landewé R, Kvien TK. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 2008, 67:212-217. 10.1136/ard.2006.068247, 17526555.
19. Hosmer D, Lemeshow S. Applied Logistic Regression 2000, New York: John Wiley & Sons, Inc, 2.
20. Jansen LM, van SD, Horst-Bruinsma IE, Dijkmans BA. One year outcome of undifferentiated polyarthritis. Ann Rheum Dis 2002, 61:700-703. 10.1136/ard.61.8.700, 1754180, 12117675.
21. Jansen AL, Horst-Bruinsma IE, van Schaardenburg D, Stadt RJ, de Koning MH, Dijkmans BA. Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 2002, 29:2074-2076.
22. Russell AS, Devani A, Maksymowych WP. The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis. J Rheumatol 2006, 33:1240-1242.
23. Helm-van Mil AH, le Cessie S, van Dongen H, Breedveld FC, Toes RE, Huizinga TW. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 2007, 56:433-440. 10.1002/art.22380, 17265478.
24. Quinn MA, Green MJ, Marzo-Ortega H, Proudman S, Karim Z, Wakefield RJ, Conaghan PG, Emery P. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis Rheum 2003, 48:3039-3045. 10.1002/art.11269, 14613264.
25. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48:2741-2749. 10.1002/art.11223, 14558078.
26. Jorgensen KT, Wiik A, Pedersen M, Hedegaard CJ, Vestergaard BF, Gislefoss RE, Kvien TK, Wohlfahrt J, Bendtzen K, Frisch M. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis 2008, 67:860-866. 10.1136/ard.2007.073825, 17644543.
27. Nielen MM, van Schaardenburg D, Reesink HW, Stadt RJ, Horst-Bruinsma IE, de Koning MH, Habibuw MR, Vandenbroucke JP, Dijkmans BA. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386. 10.1002/art.20018, 14872479.
28. van Dongen H, van Aken J, Lard LR, Visser K, Ronday HK, Hulsmans HM, Speyer I, Westedt ML, Peeters AJ, Allaart CF, Toes RE, Breedveld FC, Huizinga TW. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007, 56:1424-1432. 10.1002/art.22525, 17469099.
29. Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002, 61:290-297. 10.1136/ard.61.4.290, 1754044, 11874828.
30. Boers M. Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis Rheum 2003, 48:1771-1774. 10.1002/art.11156, 12847667.
31. Heijde DM, van Leeuwen MA, van Riel PL, Putte LB. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). J Rheumatol 1995, 22:1792-1796.
32. Combe B, Cantagrel A, Goupille P, Bozonnat MC, Sibilia J, Eliaou JF, Meyer O, Sany J, Dubois A, Daures JP, Dougados M. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis. J Rheumatol 2003, 30:2344-2349.
33. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 2004, 43:906-914. 10.1093/rheumatology/keh199, 15113999.
34. Landewe RB, Boers M, Verhoeven AC, Westhovens R, Laar MA, Markusse HM, van Denderen JC, Westedt ML, Peeters AJ, Dijkmans BA, Jacobs P, Boonen A, Heijde DM, Linden S. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002, 46:347-356. 10.1002/art.10083, 11840436.
35. Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis. Arthritis Rheum 2006, 55:864-872. 10.1002/art.22353, 17139662.
36. Horst-Bruinsma IE, Speyer I, Visser H, Breedveld FC, Hazes JM. Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol 1998, 37:1084-1088. 10.1093/rheumatology/37.10.1084, 9825747.
37. Green M, Marzo-Ortega H, McGonagle D, Wakefield R, Proudman S, Conaghan P, Gooi J, Emery P. Persistence of mild, early inflammatory arthritis: the importance of disease duration, rheumatoid factor, and the shared epitope. Arthritis Rheum 1999, 42:2184-2188. 10.1002/1529-0131(199910)42:10<2184::AID-ANR20>3.0.CO;2-2, 10524691.